US Stem Cell Inc (USRM)

[Dragon Lady]

Bid @ .0290 it's a SUB 3 CENT POS...AGAIN....LOL...

The mini P&D is OVER AND IT'S HEADING BACK DOWN THE TOILET BOWL AGAIN....

The NEGATIVE LEGAL BAGGAGE hanging around this mess of a train wreck is a lead boat drag anchor....it's GOING NOWHERE BUT DOWN...as more and more NEGATIVE REAL NEWS WILL BEING COMING IN WAVE AFTER WAVE...

This POS HAS NOWHERE TO GO BUT DOWN....when more legal charges are filed against them....

1) A UNITED STATED DEPARTMENT OF JUSTICE PERMANENT INJUNCTION SUIT AGAINST THEM which they are 100% GUARANTEED TO LOSE because the case law is already "on the books" supporting their loss

2) A FORMAL SEC INVESTIGATION w/ subpoena power investigating THE COMPANY but more importantly investigation Mike Miguel Tomas as CEO and Kristin Kristy Comella as so called "Chief Science Officer" with FAKE MAIL ORDER "Phd" and all.....WHEN THE SEC FILES CHARGES...this will go SUB ONE CENT faster than Clint Eastwood can spit a plug of chew....and it's likely that Comella and Tomas will be BANNED from serving as officers of ANY PUBLIC TRADED COMPANY for many years, or maybe banned permanently for what they've done cooking up this sham-wow scheme and dilution machine and "ALL IN THE FAMILY" share printing factory....

https://www.sec.gov/Archives/edgar/data/1388319/000118518518001385/usstem20180630_10q.htm

QUOTE FROM 10-Q...PAGE 26...LEGAL HELL FIRE :

"SEC Investigation

On or about March 1, 2018, the U.S. Securities and Exchange Commission (“Commission”), Miami Regional Office (“Commission Staff”), served a subpoena upon U.S. Stem Cell, Inc., which seeks the production of certain documents and communications. The Commission Staff is conducting a formal non-public, fact-finding inquiry of U.S. Stem Cell, Inc (“Investigation”). The Investigation is neither an allegation of wrongdoing nor a finding that any violation of law has occurred. The Company is cooperating with, and has provided information and documents to, the Commission Staff.

As part of the Investigation, on or about May 14, 2018, the Commission Staff served subpoenas upon Kristin Comella and Mike Tomas, respectively, seeking the production of certain documents and communications. Ms. Comella and Mr. Tomas responded to the respective subpoenas and provided information and documents to the Commission Staff.

At this juncture, the Company is not able to predict the duration, scope, results, or consequences of the Commission Staff’s investigation. There can be no assurance that the Investigation will be resolved in a manner that is not adverse to the Company.

Government Inquiry

On May 9, 2018, the U.S. Department of Justice filed an injunctive action, specifically United States of America v. U.S. Stem Clinic, LLC, U.S. Stem Cell, Inc., Kristin C. Comella, and Theodore Gradel. The Complaint was filed at the request of the U.S. Food and Drug Administration (FDA) and alleges that the respective defendants manufacture “stromal vascular fraction” (SVF) products from patient adipose (fat) tissue, which the companies then market as stem cell-based treatments without first obtaining necessary FDA approvals. The Company has retained counsel to defend in this action and continues discussions with the U.S. Department of Justice to achieve a favorable settlement. The Company is not able to predict the duration, scope, results, or consequences of the U.S. Department of Justice discussion or the injunctive actions. There can be no assurance that this matter will be resolved in a manner that is not adverse to the Company.

"

3) ON-GOING CIVIL LAWSUITS....they are going to become UNINSURABLE as they lose and LOSE BIG in more and more civil suits filed against them...they butchered elder ladies...NOW THEY'RE GONNA PAY DEARLY...for good......